Jump Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-32,209
Closed -$161K 2100
2022
Q2
$161K Sell
32,209
-12,994
-29% -$68.1K 0.01% 1351
2022
Q1
$322K Buy
+45,203
New +$374K 0.01% 1033
2021
Q4
Sell
-49,404
Closed -$966K 1818
2021
Q3
$966K Buy
+49,404
New +$1.88M 0.07% 299
2021
Q2
Sell
-32,409
Closed -$1.63M 1470
2021
Q1
$1.63M Buy
+32,409
New +$2.21M 0.15% 147

Other funds holding CELL

Jump Financial's CELL Position: Q3 2022 in Review

Jump Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 32,209 shares — an estimated $161K sold.

Jump Financial first reported a position in CELL in Q1 2021 and held it in 4 quarters. The position peaked at $1.63M in Q1 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Jump Financial reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Jump Financial sold 32,209 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $161K.
  • Jump Financial first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Jump Financial's PhenomeX Inc. Common Stock position peaked at $1.63M in Q1 2021.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Jump Financial's 13F filing for Q3 2022, filed 7 Nov 2022.